228 related articles for article (PubMed ID: 3074744)
1. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
[TBL] [Abstract][Full Text] [Related]
2. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
[TBL] [Abstract][Full Text] [Related]
3. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
[TBL] [Abstract][Full Text] [Related]
4. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
Hast R; Dowding C; Robak T; Goldman JM
Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
[TBL] [Abstract][Full Text] [Related]
5. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):17-28. PubMed ID: 2619501
[TBL] [Abstract][Full Text] [Related]
6. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
[TBL] [Abstract][Full Text] [Related]
7. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(6):733-47. PubMed ID: 3254121
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells.
Kubota Y; Tanaka T; Irino S
Leuk Res; 1991; 15(4):195-204. PubMed ID: 2030600
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
10. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
Robak T; Nolasco I; Hibbin J; Goldman JM
Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317
[TBL] [Abstract][Full Text] [Related]
11. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
12. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
13. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
17. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
18. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
Robak T; Korycka A
Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
[TBL] [Abstract][Full Text] [Related]
19. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations of chronic granulocytic leukemia.
Spiers AS
Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]